MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Dysphagia and dopaminergic neurodegeneration in Parkinson’s Disease

    S. Polychronis, B. Ribba, G. Nasios, E. Dardiotis, G. Pagano (Ioannina, Greece)

    Objective: To evaluate the association between dysphagia and neurodegeneration of the putaminal dopaminergic system in people with early-stage treated with symptomatic therapy and advanced-stage Parkinson’s…
  • 2023 International Congress

    Correlation of Functional Motor Assessments Used at Parkinson’s disease by Physiotherapists in Clinical Practice

    APC. Loureiro, B. Yamaguchi, VL. Israel (Curitiba, Brazil)

    Objective: The aim of this study was to verify whether there is a correlation between UPDRS motor score and non-specific assessments for PD commonly used…
  • 2023 International Congress

    Caffeine Intake Interacts with Gene Variants in Parkinson’s disease

    E. Tan, Y. Ong, X. Deng, H. Li, D. Heng, K. Narasimhalu, L. Chan, P. Kumar, W. Au, P. Ratnagopal, L. Tan (Singapore, Singapore)

    Objective: We investigate interactions of caffeine intake with PD risk variants and determine PD risk estimates in caffeine-drinkers carrying these variants. Background: Caffeine intake reduces…
  • 2023 International Congress

    Impact of istradefylline on the onset of dyskinesia in Parkinson’s Disease patients with wearing off: a randomized controlled study (ODYSSEI)

    Y. Tsuboi, T. Hasegawa, Y. Shimo, S. Kaneko, M. Tomiyama, K. Kashihara, S. Chiu, T. Yamaguchi (Fukuoka, Japan)

    Objective: To determine the effect of long-term treatment with istradefylline (IST) on the time to onset of dyskinesia in Parkinson’s disease (PD) patients with wearing-off…
  • 2023 International Congress

    Imaging the noradrenergic system in Parkinson’s disease: A [11C]Yohimbine PET and neuromelanin MRI study

    C. Laurencin, S. Lancelot, M. Huddlestone, S. Brosse, I. Merida, N. Costes, J. Redouté, S. Thobois, P. Boulinguez, B. Ballanger (Lyon, France)

    Objective: To assess two aspects of the noradrenergic system using multimodal in vivo imaging in a sample of Parkinson’s disease (PD) patients and healthy controls…
  • 2023 International Congress

    PD.ai – Detection of Parkinson’s Disease with gait-based biomarkers using AI techniques

    SJS. Rajasekar, A. Stezin (Melmaruvathur, India)

    Objective: This study evaluated the utility of Artificial Intelligence (AI) in detection of patients with Parkinson’s disease from stride dynamics. Background: Parkinson’s Disease (PD) is…
  • 2023 International Congress

    Predictive model for Identification of device-aided therapy (DAT) Candidates in Parkinson´s Disease (DELIST-PD Study)

    E. Freire-Alvarez, I. Legarda Ramirez, R. Garcia-Ramos, F. Carrillo, D. Santos-Garcia, JC. Gomez-Esteban, JC. Martinez-Castrillo, I. Martinez-Torres, CJ. Madrid Navarro, MJ. Perez Navarro, F. Valero Garcia, B. Vives Pastor, L. Muñoz-Delgado, B. Tijero, C. Morata-Martinez, R. Aler, IM. Galvan, F. Escamilla-Sevilla (Elche, Spain)

    Objective: To develop a classification algorithm based on machine learning to identify candidates for device-aided therapy among patients with Parkinson's disease (PD). Background: DATs (deep…
  • 2023 International Congress

    Oculomotor parameters measured during free viewing of video differentiate Parkinson’s disease from progressive supranuclear palsy

    H. Riek, B. White, D. Brien, B. Coe, C. Fearon, S. Arnott, D. Beaton, M. Binns, S. Black, E. Finger, A. Frank, D. Grimes, A. Lang, W. Lou, C. Marras, M. Masellis, P. Mclaughlin, J. Orange, A. Peltsch, A. Roberts, T. Steeves, K. Sunderland, B. Tan, D. Tang-Wai, C. Tartaglia, D. Munoz (Kingston, Canada)

    Objective: Characterize oculomotor phenotypes comprised of saccade, pupil, and blink behaviour for progressive supranuclear palsy (PSP) and Parkinson’s disease (PD) with differing degrees of cognitive…
  • 2023 International Congress

    Can radiofrequency lesion be better than DBS?

    J. Brainer, P. Brainer, A. Brainer, P. Brainer (Recife, Brazil)

    Objective: Pallidotomy represents a viable alternative for Parkinson disease(PD) symptoms treatment and has several important advantages, including a decreased need for access to specialists and clinical follow-up, improved affordability, and a lower infection risk, producing high long-term success rates and low morbidity rates. Background: Pallidotomy is recognized as effective for treating the symptoms of Parkinson's disease. Sometimes, radiofrequency may…
  • 2023 International Congress

    Comparing the outcome under General Anaesthesia (GA) and Monitored Anesthesia Care (MAC) of Subthalamic Nucleus (STN) – Deep Brain Stimulation (DBS) Surgery for Parkinson’s Disease (PD) in Hong Kong – A single center experience

    C. Lau, C. Zhu, V. Tang, A. Chan, K. Ma, P. Kan, A. Ng, J. Yeung, L. Cheung, V. Hui, D. Chan, D. Chan, W. Poon, V. Mok (Hong Kong, Hong Kong)

    Objective: To evaluate any difference in the clinical outcome under GA and MAC of STN DBS surgery Background: Traditionally, DBS surgery is performed under MAC…
  • « Previous Page
  • 1
  • …
  • 248
  • 249
  • 250
  • 251
  • 252
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley